More on New Chromosomal Microarray Thermo Fisher has continued to upgrade its instrumentation and services as part of its commitment to helping customers progress cytogenetic research. Thermo ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

A genetic test known as chromosomal microarray analysis (CMA) can help identify the cause of sudden infant death syndrome (SIDS) and sudden unexplained death in childhood (SUDC), finds a study led ...

Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing ...

“Thermo Fisher’s unparalleled commitment to driving innovation in chromosomal microarrays has led to advancement of cytogenetic testing capabilities,” said Kevin Lowitz, vice president and ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driv ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics, ...